To evaluate the effect of Sorafenib with TACE for intrahepatic metastasis of hepatocellular carcinoma
Phase 2
Recruiting
- Conditions
- Hepatocellular carcinoma
- Registration Number
- JPRN-UMIN000007488
- Lead Sponsor
- ippon medical school
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
1.History of malignant tumor 2.Occlusion of the main trunk or first branch of Portal vein 3.T-Bil>3.0mg/dL 4.History of interstitial pneumonitis 5.History of thromboembolism 6.Severe hypertention 7.Leukocytopenia or Thrombocytopenia
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The frequency of intrahepatic metastasis
- Secondary Outcome Measures
Name Time Method Response rate Safety